Willingdon Wealth Management lifted its position in shares of Colgate-Palmolive (NYSE:CL) by 5.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,047 shares of the company’s stock after purchasing an additional 1,620 shares during the quarter. Willingdon Wealth Management’s holdings in Colgate-Palmolive were worth $2,342,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of the company. Cetera Advisors LLC raised its position in shares of Colgate-Palmolive by 3.7% during the fourth quarter. Cetera Advisors LLC now owns 23,896 shares of the company’s stock worth $1,804,000 after purchasing an additional 863 shares during the period. Barings LLC raised its position in shares of Colgate-Palmolive by 1,410.4% during the fourth quarter. Barings LLC now owns 170,555 shares of the company’s stock worth $12,868,000 after purchasing an additional 159,263 shares during the period. Sei Investments Co. raised its position in shares of Colgate-Palmolive by 38.8% during the fourth quarter. Sei Investments Co. now owns 198,248 shares of the company’s stock worth $14,958,000 after purchasing an additional 55,413 shares during the period. New Mexico Educational Retirement Board raised its position in shares of Colgate-Palmolive by 3.0% during the fourth quarter. New Mexico Educational Retirement Board now owns 84,630 shares of the company’s stock worth $6,385,000 after purchasing an additional 2,500 shares during the period. Finally, Lyons Wealth Management LLC. acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth approximately $796,000. 71.52% of the stock is currently owned by institutional investors.
Colgate-Palmolive (NYSE:CL) opened at $70.03 on Wednesday. The stock has a market capitalization of $62,550.85, a price-to-earnings ratio of 30.72, a price-to-earnings-growth ratio of 2.65 and a beta of 0.75. The company has a debt-to-equity ratio of 27.02, a current ratio of 1.36 and a quick ratio of 1.00. Colgate-Palmolive has a 12 month low of $68.19 and a 12 month high of $77.91.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.75. The firm had revenue of $3.89 billion during the quarter, compared to the consensus estimate of $3.92 billion. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 EPS. equities research analysts expect that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd were paid a $0.40 dividend. The ex-dividend date of this dividend was Monday, January 22nd. This represents a $1.60 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 70.18%.
Several equities research analysts recently issued reports on the company. BNP Paribas downgraded Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a report on Tuesday, January 30th. Morgan Stanley decreased their price target on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. Zacks Investment Research downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, October 25th. Jefferies Group decreased their price target on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a report on Monday, October 30th. Finally, Deutsche Bank assumed coverage on Colgate-Palmolive in a report on Wednesday, December 13th. They set a “hold” rating and a $75.00 price target for the company. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $77.91.
In other news, COO Noel R. Wallace sold 126,304 shares of the stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $73.78, for a total transaction of $9,318,709.12. Following the completion of the transaction, the chief operating officer now owns 305,631 shares in the company, valued at approximately $22,549,455.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Vice Chairman Franck J. Moison sold 44,418 shares of the stock in a transaction on Tuesday, February 13th. The stock was sold at an average price of $69.87, for a total value of $3,103,485.66. Following the transaction, the insider now owns 211,048 shares of the company’s stock, valued at approximately $14,745,923.76. The disclosure for this sale can be found here. Insiders sold a total of 421,019 shares of company stock valued at $30,031,097 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.
TRADEMARK VIOLATION WARNING: This story was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this story on another website, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The original version of this story can be read at https://www.dispatchtribunal.com/2018/02/21/colgate-palmolive-cl-holdings-boosted-by-willingdon-wealth-management.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.